Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells - PubMed (original) (raw)
Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells
L Uhrbom et al. Int J Cancer. 2000.
Abstract
In human gliomas, platelet-derived growth factor (PDGF) ligand and receptor mRNA are often co-expressed, which suggests the presence of an autocrine loop. To further investigate the significance of PDGF stimulation in brain tumors, we used a previously developed mouse tumor model, in which malignant brain tumors of neuroepithelial origin were induced by injecting a murine retrovirus containing the human PDGF B-chain gene into the brains of neonatal mice. In the present investigation, we have characterized a cell line established from such an experimentally induced tumor in an INK4a-/- mouse. Cultured tumor cells expressed nestin and NG2 chondroitin sulfate proteoglycan and are thus most likely derived from an oligodendrocyte precursor cell. Tumor cells produced PDGF-B protein and displayed constitutively activated PDGF alpha receptors. Autocrine receptor activation could be blocked with the specific PDGF receptor tyrosine kinase inhibitor CGP 57148B, which led to almost complete inhibition of cell proliferation, which was much less affected by a PDGF B-chain aptamer that inhibits binding of PDGF-B to PDGF receptors and is unlikely to be able to pass through the plasma membrane. Our results imply an important role for PDGF autocrine stimulation in both initiation and progression of a subtype of gliomas.
Similar articles
- Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
Uehara H, Kim SJ, Karashima T, Shepherd DL, Fan D, Tsan R, Killion JJ, Logothetis C, Mathew P, Fidler IJ. Uehara H, et al. J Natl Cancer Inst. 2003 Mar 19;95(6):458-70. doi: 10.1093/jnci/95.6.458. J Natl Cancer Inst. 2003. PMID: 12644539 - Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
Kubo T, Piperdi S, Rosenblum J, Antonescu CR, Chen W, Kim HS, Huvos AG, Sowers R, Meyers PA, Healey JH, Gorlick R. Kubo T, et al. Cancer. 2008 May 15;112(10):2119-29. doi: 10.1002/cncr.23437. Cancer. 2008. PMID: 18338812 - PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. Dai C, et al. Genes Dev. 2001 Aug 1;15(15):1913-25. doi: 10.1101/gad.903001. Genes Dev. 2001. PMID: 11485986 Free PMC article. - Platelet-derived growth factor in human glioma.
Westermark B, Heldin CH, Nistér M. Westermark B, et al. Glia. 1995 Nov;15(3):257-63. doi: 10.1002/glia.440150307. Glia. 1995. PMID: 8586462 Review. - Platelet-derived growth factor receptors: a therapeutic target in solid tumors.
George D. George D. Semin Oncol. 2001 Oct;28(5 Suppl 17):27-33. Semin Oncol. 2001. PMID: 11740804 Review.
Cited by
- A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression.
Ustach CV, Taube ME, Hurst NJ Jr, Bhagat S, Bonfil RD, Cher ML, Schuger L, Kim HR. Ustach CV, et al. Cancer Res. 2004 Mar 1;64(5):1722-9. doi: 10.1158/0008-5472.can-03-3047. Cancer Res. 2004. PMID: 14996732 Free PMC article. - PDGF and PDGF receptors in glioma.
Nazarenko I, Hede SM, He X, Hedrén A, Thompson J, Lindström MS, Nistér M. Nazarenko I, et al. Ups J Med Sci. 2012 May;117(2):99-112. doi: 10.3109/03009734.2012.665097. Epub 2012 Apr 17. Ups J Med Sci. 2012. PMID: 22509804 Free PMC article. Review. - Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases.
Iorio AL, Ros Md, Fantappiè O, Lucchesi M, Facchini L, Stival A, Becciani S, Guidi M, Favre C, Martino Md, Genitori L, Sardi I. Iorio AL, et al. Anticancer Agents Med Chem. 2016;16(7):810-5. doi: 10.2174/1871520616666151120121928. Anticancer Agents Med Chem. 2016. PMID: 26584727 Free PMC article. Review. - Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer.
Inanç M, Er O, Karaca H, Berk V, Ozkan M, Saraymen R, Elmalı F. Inanç M, et al. Med Oncol. 2012 Dec;29(5):3119-24. doi: 10.1007/s12032-012-0250-8. Epub 2012 May 12. Med Oncol. 2012. PMID: 22580817 - Pathology and molecular genetics of oligodendroglial tumors.
Hartmann C, Mueller W, von Deimling A. Hartmann C, et al. J Mol Med (Berl). 2004 Oct;82(10):638-55. doi: 10.1007/s00109-004-0565-9. J Mol Med (Berl). 2004. PMID: 15322700 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases